Compare EVGO & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVGO | QTRX |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 195.6M | 159.9M |
| IPO Year | 2020 | 2017 |
| Metric | EVGO | QTRX |
|---|---|---|
| Price | $1.78 | $2.89 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $2.71 | ★ $3.17 |
| AVG Volume (30 Days) | ★ 6.0M | 443.4K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.39 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $54,588,000.00 | $37,632,000.00 |
| Revenue This Year | $3.82 | $3.09 |
| Revenue Next Year | $22.99 | $9.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 145.74 | 64.52 |
| 52 Week Low | $0.98 | $2.15 |
| 52 Week High | $3.55 | $8.77 |
| Indicator | EVGO | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 71.56 | 49.82 |
| Support Level | $1.71 | $2.84 |
| Resistance Level | $1.95 | $3.23 |
| Average True Range (ATR) | 0.11 | 0.24 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 88.14 | 39.02 |
EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.